Pharmacist Interventions in Rural Elderly Warfarin Patients
NCT03212898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131
Last updated 2017-07-11
Summary
The primary study goal is to explore the influence of pharmacist interventions on the effectiveness of warfarin treatment in a specific subpopulation.
Conditions
- Atrial Fibrillation
- Thrombosis
- Cardiac Failure
- Hemorrhage
Interventions
- OTHER
-
anticoagulation care
Patients in the intervention group will: 1) have a repeated pharmacist-led education on all aspects of warfarin treatment; 2) receive enhanced medication instructions and a care and follow up plan; 3) receive a pill box 4) be refered to the GP with proposal for dose change when outside the therapeutic range or therapy modification to avoid drug interactions with warfarin
Sponsors & Collaborators
-
Slaven Falamić
lead OTHER
Principal Investigators
-
Slaven Falamić, MPharm · Pharmacy Branka Marušić
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
More Related Trials
-
Long-term Safety in Atrial Fibrillation Patients
NCT00645853 ·Status: COMPLETED ·Phase: PHASE2
-
Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)
NCT04291287 ·Status: UNKNOWN
-
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
NCT03568916 ·Status: COMPLETED
-
Drug Interaction Study Between AZD3480 and Warfarin
NCT00689637 ·Status: COMPLETED ·Phase: PHASE1
-
Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)
NCT00623779 ·Status: COMPLETED ·Phase: PHASE2
-
PRescriptiOn PattERns Of Oral Anticoagulants
NCT02366338 ·Status: COMPLETED
-
Apixaban in Patients With Left Ventricular Thrombus
NCT05208398 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
NCT00691470 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Apixaban Dose Reduction in Patients With Elevated Drug Levels
NCT02809469 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prescription Support Tool for Oral Antithrombotic Combinations
NCT03630874 ·Status: COMPLETED ·Phase: NA
-
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
NCT01214122 ·Status: WITHDRAWN ·Phase: PHASE1
-
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
NCT02596126 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects
NCT01311622 ·Status: COMPLETED ·Phase: PHASE1
-
Vorapaxar on Thrombin Generation and Coagulability
NCT03207451 ·Status: COMPLETED ·Phase: PHASE4
-
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00412984 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
NCT01245608 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
Warfarin and Antiplatelet Therapy in Chronic Heart Failure
NCT00007683 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061 ·Status: UNKNOWN
-
Treatment Pattern of Oral Anticoagulants (OAC) in Japan
NCT02982863 ·Status: COMPLETED
-
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
NCT02921126 ·Status: COMPLETED
-
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
NCT00580216 ·Status: TERMINATED ·Phase: PHASE3
-
Colchicine in Atrial Fibrillation to Prevent Stroke
NCT02282098 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
NCT05438888 ·Status: COMPLETED
-
Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization
NCT03889574 ·Status: COMPLETED